FDA has approved the 1st BTK (Brutonâs tyrosine kinase) inhibitor (Jaypirca⢠or pirtobrutinib) for adults with refr
Tweet Content
FDA has approved the 1st BTK (Bruton’s tyrosine kinase) inhibitor (Jaypirca™ or pirtobrutinib) for adults with refractory mantle cell lymphoma. BTK inhibitors are also being developed for use in MS, RA, SLE, pemphigus & more https://t.co/gDHbcDpNnT https://t.co/oL0nldQ1fN
Links
Show on Archive Page
On
Display in Search Results
On
PDQ
Off